Vilin Bio Med (NSE:VILINBIO) Cash-to-Debt : 1.18 (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Vilin Bio Med's cash to debt ratio for the quarter that ended in Sep. 2023 was 1.18.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Vilin Bio Med could pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for Vilin Bio Med's Cash-to-Debt or its related term are showing as below:

NSE:VILINBIO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01 Med: 0.01 Max: 1.18
Current: 1.18

During the past 3 years, Vilin Bio Med's highest Cash to Debt Ratio was 1.18. The lowest was 0.01. And the median was 0.01.

NSE:VILINBIO's Cash-to-Debt is ranked better than
53.3% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs NSE:VILINBIO: 1.18

Vilin Bio Med Cash-to-Debt Historical Data

The historical data trend for Vilin Bio Med's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Vilin Bio Med Cash-to-Debt Chart

Vilin Bio Med Annual Data

Trend

Mar20

Mar21

Mar22

Cash-to-Debt

0.02

0.01

Vilin Bio Med Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Sep23
Cash-to-Debt	0.02	0.01	0.01	N/A	1.18

Competitive Comparison of Vilin Bio Med's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vilin Bio Med's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Vilin Bio Med's Cash-to-Debt falls into.

Vilin Bio Med Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Vilin Bio Med's Cash to Debt Ratio for the fiscal year that ended in Mar. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.39	/	(45.656	+	7.34)
	=	0.01

Vilin Bio Med's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	65.324	/	(52.717	+	2.525)
	=	1.18

Vilin Bio Med (NSE:VILINBIO) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Vilin Bio Med Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009

Website

http://www.vilinbiomed.co.in

Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines